Zamifenacin
Alternative Names: UK 76654Latest Information Update: 31 Oct 1995
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Irritable bowel syndrome